HL7 Europe Imaging Study Report
0.1.0 - ci-build 150

HL7 Europe Imaging Study Report, published by HL7 Europe. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/imaging/ and changes regularly. See the Directory of published versions

ConceptMap: Mapping of A.5.3 Adverse reaction (Adverse reactions manifested during imaging investigation. (Experimental)

Official URL: http://hl7.eu/fhir/imaging/ConceptMap/A-5.3-ImagingProcedureAdverseReactionMapping Version: 0.1.0
Draft as of 2025-03-18 Computable Name: A.5.3

Copyright/Legal: Used by permission of HL7 Europe, all rights reserved Creative Commons License

This concept map defines the mapping between the eHN A.5.3 Adverse reaction section and the FHIR profiles. In FHIR, adverse reactions are modelled using the AdverseEvent resource.

Generated Narrative: ConceptMap A-5.3-ImagingProcedureAdverseReactionMapping

Mapping from A.5.3 Adverse reaction to (not specified)


Group 1 Mapping from A.5.3 Adverse reaction to Adverse Event

Source CodeRelationshipTarget Code
allergyDescription (A.5.3.1 Allergy description)is equivalent tocode.text (Description of event when not coded.)
allergyDescription (A.5.3.1 Allergy description)is equivalent tonote (Description of event additional information is recorded.)
typeOfPropensity (A.5.3.2 Type of propensity)is narrower thancategory
allergyManifestation (A.5.3.3 Allergy manifestation)is equivalent toresultingEffect
severity (A.5.3.4 Severity)is broader thanseriousness
criticality (A.5.3.5 Criticality)is equivalent toextension.ImAdverseEventCriticality
onsetDate (A.5.3.6 Onset date)is equivalent tooccurance[dateTime]
certainty (A.5.3.7 Certainty)is broader thansuspectEntity.causality.entityRelatedness
agentOrAllergen (A.5.3.8 Agent or Allergen)is narrower thansuspectEntity.instance:medicationAdministered (When no formal allergy intolerance has been diagnosed.)
agentOrAllergen (A.5.3.8 Agent or Allergen)is broader thancontributingFactor[allergy]

Group 2 Mapping from A.5.3 Adverse reaction to Allergic Reaction

Source CodeRelationshipTarget Code
criticality (A.5.3.5 Criticality)is equivalent tocriticallity
allergyManifestation (A.5.3.3 Allergy manifestation)is equivalent toreaction.manifestation
severity (A.5.3.4 Severity)is equivalent toreaction.severity
onsetDate (A.5.3.6 Onset date)is equivalent toreacton.onset
certainty (A.5.3.7 Certainty)is equivalent toextension.allergyCertainty
agentOrAllergen (A.5.3.8 Agent or Allergen)is equivalent toreaction.substance